Home / Companies / Caris Life Sciences, Inc. / 4 Jun 2026
Caris Life Sciences, Inc.: meeting of 4 Jun 2026
Votes reported on Form N-PX, item by item
137 Form N-PX filers reported votes at the Caris Life Sciences, Inc. meeting of 4 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
10 nominees; 64.4% of reported votes for; 90 filers withheld from or voted against at least one nominee.
2,454 vote records from 136 filers. 43 of the 133 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1 vote records from 1 filers. No filer marked a management recommendation, so no against-management figure is reported. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
249 vote records from 136 filers. 1 of the 133 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 3. Auditor |
|---|---|---|
| Vanguard | Abstain or withhold * | For |
| BlackRock and iShares | For | For |
| Fidelity | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| American Century | Split or no vote | Split or no vote |
| Franklin Templeton | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | Abstain or withhold * | For |
| ProShares and ProFunds | Abstain or withhold * | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| J.P. Morgan | For | For |
| Goldman Sachs | For | For |
| PGIM and Prudential | For | For |
| Jackson National funds | For | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Voya | For | For |
| First Trust | Abstain or withhold * | For |
| Russell Investments | For | For |
| Nationwide | For | For |
| Victory Capital | Abstain or withhold * | For |
| Brighthouse Funds | For | For |
| Columbia Threadneedle | For | For |
| BNY Mellon | Split or no vote | For |
| Principal | For | For |
| Capital Group and American Funds | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| MFS | For | For |
| Transamerica | For | For |
| Federated Hermes | For | For |
| DWS | Abstain or withhold * | For |
| MassMutual | For | For |
| Virtus | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Caris Life Sciences, Inc. meeting?
137 Form N-PX filers reported votes at the meeting of 4 Jun 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Caris Life Sciences, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Caris Life Sciences, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Caris Life Sciences, Inc. with a meeting date within three days of 4 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.